Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Zylox-Tonbridge Medical Technology Co Ltd
Income from Continuing Operations
Zylox-Tonbridge Medical Technology Co Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
|
Income from Continuing Operations
-¥78.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Income from Continuing Operations
¥522.1m
|
CAGR 3-Years
71%
|
CAGR 5-Years
99%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Income from Continuing Operations
¥1.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
16%
|
CAGR 10-Years
19%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Income from Continuing Operations
¥12.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Income from Continuing Operations
¥672.5m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
5%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Income from Continuing Operations
¥2B
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zylox-Tonbridge Medical Technology Co Ltd
Glance View
Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.
See Also
What is Zylox-Tonbridge Medical Technology Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
-78.7m
CNY
Based on the financial report for Dec 31, 2023, Zylox-Tonbridge Medical Technology Co Ltd's Income from Continuing Operations amounts to -78.7m CNY.
What is Zylox-Tonbridge Medical Technology Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
8%
Over the last year, the Income from Continuing Operations growth was 31%. The average annual Income from Continuing Operations growth rates for Zylox-Tonbridge Medical Technology Co Ltd have been 8% over the past three years .
You don't have any saved screeners yet